AksharChem (India) Limited

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, DOMS.BO has a market cap of 144.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while DOMS.BO trades at ₹2,368.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas DOMS.BO's P/E ratio is 65.05. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to DOMS.BO's ROE of +0.21%. Regarding short-term risk, AKSCHEM.BO is less volatile compared to DOMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check DOMS.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while HEXAWARE.NS trades at ₹470.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, AKSCHEM.BO is more volatile compared to HEXAWARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check HEXAWARE.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SAFARIND.BO has a market cap of 91.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SAFARIND.BO trades at ₹1,915.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SAFARIND.BO's P/E ratio is 1394.97. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SAFARIND.BO's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SAFARIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SAFARIND.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SHREMINVIT.NS has a market cap of 72.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SHREMINVIT.NS trades at ₹118.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SHREMINVIT.NS's P/E ratio is 7.51. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SHREMINVIT.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. AKSCHEM.BO has daily volatility of 3.49 and SHREMINVIT.NS has daily volatility of N/A.Check SHREMINVIT.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ENTERO.NS has a market cap of 46.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ENTERO.NS trades at ₹1,028.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ENTERO.NS's P/E ratio is 40.96. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ENTERO.NS's ROE of +0.06%. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ENTERO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ENTERO.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ORIANA.NS has a market cap of 39.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ORIANA.NS trades at ₹1,936.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ORIANA.NS's P/E ratio is 24.21. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ORIANA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ORIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ORIANA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, MEDIASSIST.NS has a market cap of 28.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while MEDIASSIST.NS trades at ₹388.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas MEDIASSIST.NS's P/E ratio is 49.28. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to MEDIASSIST.NS's ROE of +0.10%. Regarding short-term risk, AKSCHEM.BO is more volatile compared to MEDIASSIST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check MEDIASSIST.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, RPTECH.NS has a market cap of 22.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while RPTECH.NS trades at ₹344.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas RPTECH.NS's P/E ratio is 9.30. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to RPTECH.NS's ROE of +0.14%. Regarding short-term risk, AKSCHEM.BO is less volatile compared to RPTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check RPTECH.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ALPEXSOLAR.NS has a market cap of 19.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ALPEXSOLAR.NS trades at ₹780.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ALPEXSOLAR.NS's P/E ratio is 14.68. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ALPEXSOLAR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ALPEXSOLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ALPEXSOLAR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VMARCIND.NS has a market cap of 16.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VMARCIND.NS trades at ₹686.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VMARCIND.NS's P/E ratio is 26.87. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VMARCIND.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to VMARCIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VMARCIND.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, AIMTRON.NS has a market cap of 16.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while AIMTRON.NS trades at ₹798.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas AIMTRON.NS's P/E ratio is 60.00. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to AIMTRON.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to AIMTRON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check AIMTRON.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KRISHNADEF.NS has a market cap of 15.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KRISHNADEF.NS trades at ₹1,001.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KRISHNADEF.NS's P/E ratio is 49.25. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KRISHNADEF.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to KRISHNADEF.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KRISHNADEF.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ASHIKA.BO has a market cap of 14.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ASHIKA.BO trades at ₹369.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ASHIKA.BO's P/E ratio is -28.54. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ASHIKA.BO's ROE of +0.02%. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ASHIKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ASHIKA.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GRNLAMIND.BO has a market cap of 13.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GRNLAMIND.BO trades at ₹556.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GRNLAMIND.BO's P/E ratio is 19.03. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GRNLAMIND.BO's ROE of -0.01%. Regarding short-term risk, AKSCHEM.BO is more volatile compared to GRNLAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GRNLAMIND.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VINYAS.NS has a market cap of 12.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VINYAS.NS trades at ₹993.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VINYAS.NS's P/E ratio is 58.43. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VINYAS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to VINYAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VINYAS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, LEMERITE.NS has a market cap of 11.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while LEMERITE.NS trades at ₹456.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas LEMERITE.NS's P/E ratio is 94.55. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to LEMERITE.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to LEMERITE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check LEMERITE.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KODYTECH.NS has a market cap of 11.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KODYTECH.NS trades at ₹882.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KODYTECH.NS's P/E ratio is 70.51. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KODYTECH.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to KODYTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KODYTECH.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GPTHEALTH.NS has a market cap of 10.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GPTHEALTH.NS trades at ₹122.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GPTHEALTH.NS's P/E ratio is 25.43. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GPTHEALTH.NS's ROE of +0.17%. Regarding short-term risk, AKSCHEM.BO is more volatile compared to GPTHEALTH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GPTHEALTH.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SARTELE.NS has a market cap of 10.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SARTELE.NS trades at ₹214.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SARTELE.NS's P/E ratio is 12.83. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SARTELE.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to SARTELE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SARTELE.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KARNIKA.NS has a market cap of 9.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KARNIKA.NS trades at ₹144.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KARNIKA.NS's P/E ratio is 45.24. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KARNIKA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to KARNIKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KARNIKA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VILAS.NS has a market cap of 9.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VILAS.NS trades at ₹399.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VILAS.NS's P/E ratio is 21.15. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VILAS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to VILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VILAS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, TAC.NS has a market cap of 8.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while TAC.NS trades at ₹443.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas TAC.NS's P/E ratio is 60.74. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to TAC.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to TAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check TAC.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, REMUS.NS has a market cap of 8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while REMUS.NS trades at ₹679.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas REMUS.NS's P/E ratio is 18.97. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to REMUS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to REMUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check REMUS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PARIN.NS has a market cap of 7.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PARIN.NS trades at ₹719.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PARIN.NS's P/E ratio is 102.68. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PARIN.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to PARIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PARIN.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ACCENTMIC.NS has a market cap of 7.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ACCENTMIC.NS trades at ₹326.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ACCENTMIC.NS's P/E ratio is 22.05. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ACCENTMIC.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ACCENTMIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ACCENTMIC.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, DENTALKART.NS has a market cap of 7.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while DENTALKART.NS trades at ₹474.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas DENTALKART.NS's P/E ratio is 44.85. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to DENTALKART.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to DENTALKART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check DENTALKART.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ZTECH.NS has a market cap of 6.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ZTECH.NS trades at ₹514.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ZTECH.NS's P/E ratio is 32.03. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ZTECH.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ZTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ZTECH.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GGBL.NS has a market cap of 6.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GGBL.NS trades at ₹258.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GGBL.NS's P/E ratio is 13.46. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GGBL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to GGBL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GGBL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, APS.NS has a market cap of 6.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while APS.NS trades at ₹329.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas APS.NS's P/E ratio is 15.56. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to APS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to APS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check APS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KILPEST.BO has a market cap of 6.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KILPEST.BO trades at ₹808.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KILPEST.BO's P/E ratio is 18.32. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KILPEST.BO's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to KILPEST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KILPEST.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, BAHETI.NS has a market cap of 6.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while BAHETI.NS trades at ₹586.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas BAHETI.NS's P/E ratio is 34.18. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to BAHETI.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to BAHETI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check BAHETI.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, DPEL.NS has a market cap of 6.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while DPEL.NS trades at ₹289.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas DPEL.NS's P/E ratio is 63.33. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to DPEL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to DPEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check DPEL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KRITIIND.BO has a market cap of 5.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KRITIIND.BO trades at ₹117.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KRITIIND.BO's P/E ratio is 31.62. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KRITIIND.BO's ROE of -0.05%. Regarding short-term risk, AKSCHEM.BO is less volatile compared to KRITIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KRITIIND.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, MOS.NS has a market cap of 5.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while MOS.NS trades at ₹21.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas MOS.NS's P/E ratio is 40.00. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to MOS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to MOS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check MOS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GICL.NS has a market cap of 5.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GICL.NS trades at ₹50.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GICL.NS's P/E ratio is 172.41. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GICL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to GICL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GICL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, CELLECOR.NS has a market cap of 5.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while CELLECOR.NS trades at ₹26.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas CELLECOR.NS's P/E ratio is 18.17. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to CELLECOR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to CELLECOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check CELLECOR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, TIRUPATI.NS has a market cap of 5.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while TIRUPATI.NS trades at ₹539.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas TIRUPATI.NS's P/E ratio is 38.10. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to TIRUPATI.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to TIRUPATI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check TIRUPATI.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PCCL.NS has a market cap of 5.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PCCL.NS trades at ₹210.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PCCL.NS's P/E ratio is 57.42. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PCCL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to PCCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PCCL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GIRIRAJ.NS has a market cap of 5.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GIRIRAJ.NS trades at ₹142.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GIRIRAJ.NS's P/E ratio is 19.79. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GIRIRAJ.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to GIRIRAJ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GIRIRAJ.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, BASILIC.NS has a market cap of 5.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while BASILIC.NS trades at ₹225.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas BASILIC.NS's P/E ratio is 13.92. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to BASILIC.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to BASILIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check BASILIC.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, UNIHEALTH.NS has a market cap of 4.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while UNIHEALTH.NS trades at ₹333.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas UNIHEALTH.NS's P/E ratio is 32.44. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to UNIHEALTH.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to UNIHEALTH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check UNIHEALTH.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SJLOGISTIC.NS has a market cap of 4.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SJLOGISTIC.NS trades at ₹314.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SJLOGISTIC.NS's P/E ratio is 8.87. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SJLOGISTIC.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SJLOGISTIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SJLOGISTIC.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VINSYS.NS has a market cap of 4.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VINSYS.NS trades at ₹314.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VINSYS.NS's P/E ratio is 15.60. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VINSYS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to VINSYS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VINSYS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, EFFWA.NS has a market cap of 4.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while EFFWA.NS trades at ₹206.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas EFFWA.NS's P/E ratio is 23.07. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to EFFWA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to EFFWA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check EFFWA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KNAGRI.NS has a market cap of 4.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KNAGRI.NS trades at ₹180.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KNAGRI.NS's P/E ratio is 12.29. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KNAGRI.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to KNAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KNAGRI.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, COOLCAPS.NS has a market cap of 4.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while COOLCAPS.NS trades at ₹32.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas COOLCAPS.NS's P/E ratio is 30.82. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to COOLCAPS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to COOLCAPS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check COOLCAPS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VIVIANA.NS has a market cap of 4.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VIVIANA.NS trades at ₹703.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VIVIANA.NS's P/E ratio is 34.20. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VIVIANA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to VIVIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VIVIANA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GRETEX.NS has a market cap of 4.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GRETEX.NS trades at ₹263.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GRETEX.NS's P/E ratio is 281.25. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GRETEX.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to GRETEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GRETEX.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PRAMARA.NS has a market cap of 4.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PRAMARA.NS trades at ₹364.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PRAMARA.NS's P/E ratio is 70.36. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PRAMARA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to PRAMARA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PRAMARA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PROV.NS has a market cap of 4.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PROV.NS trades at ₹1,200.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PROV.NS's P/E ratio is 45.28. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PROV.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to PROV.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PROV.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, VISHNUINFR.NS has a market cap of 4.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while VISHNUINFR.NS trades at ₹165.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas VISHNUINFR.NS's P/E ratio is 13.95. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to VISHNUINFR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to VISHNUINFR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check VISHNUINFR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, MEGATHERM.NS has a market cap of 4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while MEGATHERM.NS trades at ₹214.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas MEGATHERM.NS's P/E ratio is 18.64. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to MEGATHERM.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to MEGATHERM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check MEGATHERM.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ABSMARINE.NS has a market cap of 4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ABSMARINE.NS trades at ₹161.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ABSMARINE.NS's P/E ratio is 14.07. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ABSMARINE.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ABSMARINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ABSMARINE.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SYSTANGO.NS has a market cap of 3.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SYSTANGO.NS trades at ₹258.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SYSTANGO.NS's P/E ratio is 11.76. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SYSTANGO.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to SYSTANGO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SYSTANGO.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SHIVAUM.NS has a market cap of 3.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SHIVAUM.NS trades at ₹275.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SHIVAUM.NS's P/E ratio is 74.32. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SHIVAUM.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SHIVAUM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SHIVAUM.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ATMASTCO.NS has a market cap of 3.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ATMASTCO.NS trades at ₹152.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ATMASTCO.NS's P/E ratio is 19.14. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ATMASTCO.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ATMASTCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ATMASTCO.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, CGRAPHICS.NS has a market cap of 3.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while CGRAPHICS.NS trades at ₹145.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas CGRAPHICS.NS's P/E ratio is 16.22. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to CGRAPHICS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to CGRAPHICS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check CGRAPHICS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SUPREMEPWR.NS has a market cap of 3.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SUPREMEPWR.NS trades at ₹141.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SUPREMEPWR.NS's P/E ratio is 16.77. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SUPREMEPWR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to SUPREMEPWR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SUPREMEPWR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, WSIND.BO has a market cap of 3.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while WSIND.BO trades at ₹131.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas WSIND.BO's P/E ratio is -6.02. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to WSIND.BO's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to WSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check WSIND.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, HIGREEN.NS has a market cap of 3.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while HIGREEN.NS trades at ₹133.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas HIGREEN.NS's P/E ratio is 32.25. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to HIGREEN.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to HIGREEN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check HIGREEN.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, INFINIUM.NS has a market cap of 3.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while INFINIUM.NS trades at ₹210.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas INFINIUM.NS's P/E ratio is 35.64. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to INFINIUM.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to INFINIUM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check INFINIUM.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PRIZOR.NS has a market cap of 3.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PRIZOR.NS trades at ₹299.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PRIZOR.NS's P/E ratio is 27.91. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PRIZOR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to PRIZOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PRIZOR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SAAKSHI.NS has a market cap of 3.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SAAKSHI.NS trades at ₹182.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SAAKSHI.NS's P/E ratio is 69.21. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SAAKSHI.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to SAAKSHI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SAAKSHI.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ANNAPURNA.NS has a market cap of 3.2B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ANNAPURNA.NS trades at ₹173.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ANNAPURNA.NS's P/E ratio is 14.39. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ANNAPURNA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ANNAPURNA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ANNAPURNA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SHREEKARNI.NS has a market cap of 3.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SHREEKARNI.NS trades at ₹434.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SHREEKARNI.NS's P/E ratio is 18.90. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SHREEKARNI.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SHREEKARNI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SHREEKARNI.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SEJAL.BO has a market cap of 3.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SEJAL.BO trades at ₹307.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SEJAL.BO's P/E ratio is N/A. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SEJAL.BO's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SEJAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SEJAL.BO's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, DUGLOBAL.NS has a market cap of 3.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while DUGLOBAL.NS trades at ₹39.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas DUGLOBAL.NS's P/E ratio is 75.18. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to DUGLOBAL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to DUGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check DUGLOBAL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, TECHLABS.NS has a market cap of 3.1B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while TECHLABS.NS trades at ₹168.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas TECHLABS.NS's P/E ratio is 26.53. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to TECHLABS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to TECHLABS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check TECHLABS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ESFL.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ESFL.NS trades at ₹116.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ESFL.NS's P/E ratio is 31.27. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ESFL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to ESFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ESFL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, EFACTOR.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while EFACTOR.NS trades at ₹243.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas EFACTOR.NS's P/E ratio is 12.11. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to EFACTOR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to EFACTOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check EFACTOR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, RBMINFRA.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while RBMINFRA.NS trades at ₹362.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas RBMINFRA.NS's P/E ratio is 12.86. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to RBMINFRA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to RBMINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check RBMINFRA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, INFOLLION.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while INFOLLION.NS trades at ₹315.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas INFOLLION.NS's P/E ratio is 21.81. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to INFOLLION.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to INFOLLION.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check INFOLLION.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, TRANSTEEL.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while TRANSTEEL.NS trades at ₹139.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas TRANSTEEL.NS's P/E ratio is 22.32. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to TRANSTEEL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to TRANSTEEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check TRANSTEEL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ARIHANTACA.NS has a market cap of 3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ARIHANTACA.NS trades at ₹466.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ARIHANTACA.NS's P/E ratio is 50.00. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ARIHANTACA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ARIHANTACA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ARIHANTACA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SHERA.NS has a market cap of 2.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SHERA.NS trades at ₹122.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SHERA.NS's P/E ratio is 15.26. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SHERA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SHERA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SHERA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, MASON.NS has a market cap of 2.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while MASON.NS trades at ₹174.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas MASON.NS's P/E ratio is 85.94. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to MASON.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to MASON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check MASON.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SAHAJSOLAR.NS has a market cap of 2.9B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SAHAJSOLAR.NS trades at ₹141.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SAHAJSOLAR.NS's P/E ratio is 12.13. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SAHAJSOLAR.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SAHAJSOLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SAHAJSOLAR.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PHANTOMFX.NS has a market cap of 2.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PHANTOMFX.NS trades at ₹210.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PHANTOMFX.NS's P/E ratio is 10.08. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PHANTOMFX.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to PHANTOMFX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PHANTOMFX.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, WTICAB.NS has a market cap of 2.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while WTICAB.NS trades at ₹117.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas WTICAB.NS's P/E ratio is 12.09. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to WTICAB.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to WTICAB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check WTICAB.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SHEETAL.NS has a market cap of 2.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SHEETAL.NS trades at ₹246.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SHEETAL.NS's P/E ratio is 30.15. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SHEETAL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SHEETAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SHEETAL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, DYNAMIC.NS has a market cap of 2.8B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while DYNAMIC.NS trades at ₹121.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas DYNAMIC.NS's P/E ratio is 17.17. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to DYNAMIC.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to DYNAMIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check DYNAMIC.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, SKP.NS has a market cap of 2.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while SKP.NS trades at ₹167.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas SKP.NS's P/E ratio is 50.89. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to SKP.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to SKP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check SKP.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, YASHOPTICS.NS has a market cap of 2.7B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while YASHOPTICS.NS trades at ₹108.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas YASHOPTICS.NS's P/E ratio is 33.44. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to YASHOPTICS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to YASHOPTICS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check YASHOPTICS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, CPS.NS has a market cap of 2.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while CPS.NS trades at ₹1,201.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas CPS.NS's P/E ratio is 1445.19. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to CPS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to CPS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check CPS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GSMFOILS.NS has a market cap of 2.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GSMFOILS.NS trades at ₹202.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GSMFOILS.NS's P/E ratio is 16.39. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GSMFOILS.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to GSMFOILS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GSMFOILS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, CMNL.NS has a market cap of 2.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while CMNL.NS trades at ₹105.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas CMNL.NS's P/E ratio is 26.59. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to CMNL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to CMNL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check CMNL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, LAKSHVILAS.NS has a market cap of 2.6B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while LAKSHVILAS.NS trades at ₹7.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas LAKSHVILAS.NS's P/E ratio is -0.34. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to LAKSHVILAS.NS's ROE of -0.54%. Regarding short-term risk, AKSCHEM.BO is less volatile compared to LAKSHVILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check LAKSHVILAS.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, CHAVDA.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while CHAVDA.NS trades at ₹105.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas CHAVDA.NS's P/E ratio is 12.03. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to CHAVDA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to CHAVDA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check CHAVDA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KRISHCA.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KRISHCA.NS trades at ₹176.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KRISHCA.NS's P/E ratio is 21.37. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KRISHCA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to KRISHCA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KRISHCA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, FELIX.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while FELIX.NS trades at ₹185.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas FELIX.NS's P/E ratio is 17.50. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to FELIX.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to FELIX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check FELIX.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, COMMITTED.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while COMMITTED.NS trades at ₹211.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas COMMITTED.NS's P/E ratio is 23.91. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to COMMITTED.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to COMMITTED.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check COMMITTED.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, KOTYARK.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while KOTYARK.NS trades at ₹240.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas KOTYARK.NS's P/E ratio is 17.18. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to KOTYARK.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to KOTYARK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check KOTYARK.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, JAINAM.NS has a market cap of 2.5B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while JAINAM.NS trades at ₹209.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas JAINAM.NS's P/E ratio is -107.69. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to JAINAM.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to JAINAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check JAINAM.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, AVPINFRA.NS has a market cap of 2.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while AVPINFRA.NS trades at ₹98.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas AVPINFRA.NS's P/E ratio is 20.11. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to AVPINFRA.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to AVPINFRA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check AVPINFRA.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, GOYALSALT.NS has a market cap of 2.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while GOYALSALT.NS trades at ₹139.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas GOYALSALT.NS's P/E ratio is 18.11. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to GOYALSALT.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to GOYALSALT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check GOYALSALT.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, ANLON.NS has a market cap of 2.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while ANLON.NS trades at ₹378.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas ANLON.NS's P/E ratio is 35.80. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to ANLON.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to ANLON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check ANLON.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, TCL.NS has a market cap of 2.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while TCL.NS trades at ₹98.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas TCL.NS's P/E ratio is 18.99. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to TCL.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is more volatile compared to TCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AKSCHEM.BO.Check TCL.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, PRATHAM.NS has a market cap of 2.4B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while PRATHAM.NS trades at ₹130.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas PRATHAM.NS's P/E ratio is 17.25. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to PRATHAM.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to PRATHAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check PRATHAM.NS's competition here

AKSCHEM.BO plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AKSCHEM.BO stands at 2.3B. In comparison, AKIKO.NS has a market cap of 2.3B. Regarding current trading prices, AKSCHEM.BO is priced at ₹281.30, while AKIKO.NS trades at ₹214.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AKSCHEM.BO currently has a P/E ratio of 19.24, whereas AKIKO.NS's P/E ratio is 28.87. In terms of profitability, AKSCHEM.BO's ROE is +0.02%, compared to AKIKO.NS's ROE of N/A. Regarding short-term risk, AKSCHEM.BO is less volatile compared to AKIKO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AKSCHEM.BO.Check AKIKO.NS's competition here